EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions

Yanrong Ma, Jing Mu, Xueyan Gou, Xinan Wu

Precision Clinical Medicine · 07.01.2025 · 8 (1)

DOI: 10.1093/pcmedi/pbaf004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Precision Clinical Medicine, online erschienen am 22.02.2025. Verfasst von Yanrong Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacogenomics, therapeutic drug monitoring, and the assessments of hepatic and renal function have made significant contributions to the advancement of individualized medicine. However, their lack of direct correlation with protein abundance/non-genetic factors, target drug concentration, and drug metabolism/excretion significantly limits their application in precision drug therapy. The primary task of precision medicine is to accurately determine drug dosage, which depends on a precise assessment of the ability to handle drugs in vivo, and drug metabolizing enzymes and transporters are critical determinants of drug disposition in the body. Therefore, accurately evaluating the functions of these enzymes and transporters is key to assessing the capacity to handle drugs and predicting drug concentrations in target organs. Recent advancements in the evaluation of enzyme and transporter functions using exogenous probes and endogenous biomarkers show promise in advancing personalized medicine. This article aims to provide a comprehensive overview of the latest research on markers used for the functional evaluation of drug-metabolizing enzymes and transporters. It also explores the application of marker omics in systematically assessing their functions, thereby laying a foundation for advancing precision pharmacotherapy.

Schlagwörter

Stichwörter der Autor:innen

biomarkerdrug metabolizing enzymedrug transporterprecision medicineprobe

Autor:innen und Institutionen

  • The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China.
  • Department of Pharmacy, The First Hospital of Lanzhou University, Lanzhou 730000, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Gansu Province

Zitieren

APA

Ma, Y., Mu, J., Gou, X., & Wu, X. (2025). Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions. Precision Clinical Medicine, 8(1). https://doi.org/10.1093/pcmedi/pbaf004

Vancouver

Ma Y, Mu J, Gou X, Wu X. Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions. Precision Clinical Medicine. 2025;8(1). doi:10.1093/pcmedi/pbaf004

BibTeX
@article{Ma2025,
  author = {Ma, Yanrong and Mu, Jing and Gou, Xueyan and Wu, Xinan},
  title = {Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions},
  journal = {Precision Clinical Medicine},
  year = {2025},
  volume = {8},
  number = {1},
  doi = {10.1093/pcmedi/pbaf004}
}
Kostenlos starten →